Paracetamol Metabolism After Liver Surgery
NCT01770041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2014-10-16
Summary
This observational study will assess the metabolic pathways of paracetamol that are utilised after liver resection.
Conditions
- Liver Resection
- Paracetamol Administration
Interventions
- OTHER
-
Paracetamol (observation of routine administration)
Normal administration of paracetamol as prescribed by operating surgeon
Sponsors & Collaborators
-
NHS Lothian
collaborator OTHER_GOV -
University of Edinburgh
lead OTHER
Principal Investigators
-
Michael J Hughes, MBChB · University of Edinburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-05-31
- Completion
- 2014-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma
NCT02526043 ·Status: UNKNOWN ·Phase: NA
-
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
NCT04076631 ·Status: UNKNOWN
-
Liver Regeneration After Liver Resection
NCT01220986 ·Status: UNKNOWN
-
Esophagectomy in Patients With Liver Cirrhosis
NCT04809870 ·Status: COMPLETED
-
Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing
NCT04597710 ·Status: ACTIVE_NOT_RECRUITING
-
Metabolic Surgery for Steato-Hepatitis
NCT04282005 ·Status: UNKNOWN ·Phase: NA
-
Plasma and Hemodynamic Markers During Hepatectomy
NCT01700231 ·Status: COMPLETED
-
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
NCT00844779 ·Status: UNKNOWN
-
Mitochondrial Metabolism and Hepatic Complications of Obesity
NCT03302481 ·Status: WITHDRAWN ·Phase: NA
-
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
NCT03213314 ·Status: COMPLETED ·Phase: NA
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Energy Expenditure and Regeneration Following Liver Resection Resection
NCT02031094 ·Status: COMPLETED
-
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
NCT01768741 ·Status: UNKNOWN ·Phase: NA
-
Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy
NCT03594188 ·Status: COMPLETED ·Phase: NA
-
Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging
NCT04705194 ·Status: UNKNOWN
-
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
NCT01441453 ·Status: UNKNOWN ·Phase: NA
-
Hepatoprotective Effect of Remote vs Local Preconditioning of Liver
NCT03130920 ·Status: COMPLETED ·Phase: NA
-
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
NCT04578301 ·Status: RECRUITING
-
Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection
NCT04100304 ·Status: UNKNOWN ·Phase: NA
-
International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
NCT04652271 ·Status: UNKNOWN
-
Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro
NCT04510935 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
NCT03313648 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors for Major Complications After Liver Resection
NCT03967067 ·Status: COMPLETED
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN